Publications by authors named "Giulia Spallone"

Claim this Profile
R
Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study.
Mario Valenti, Sara Di Giulio, Andrea Carugno, Pasquale Frascione, Angelo Valerio Marzano, Giulia Spallone

Dermatol Reports· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma.
Cosimo Di Raimondo, Raffaele Dante Caposiena Caro, Diana Spallone, Dionisio Silvaggio, Paolo Lombardo, Giulia Spallone

Int J Dermatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Maria Cristina Rapanotti, Tara Mayte Suarez Viguria, Giulia Spallone, Alessandro Terrinoni, Piero Rossi

Cancer Treat Res Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus 2019 disease and skin cancer: a single center experience.
Cosimo DI Raimondo, Giulia Spallone, Dionisio Silvaggio, Paolo Lombardo, Arianna Piccolo

Ital J Dermatol Venerol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of spontaneous regression of metastatic skin undifferentiated carcinoma.
Mauro Mazzeo, Dioniosio Silvaggio, Flavia Lozzi, Giulia Spallone, Paolo Lombardo

Ital J Dermatol Venerol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.
Elena Campione, Monia Di Prete, Flavia Lozzi, Caterina Lanna, Giulia Spallone

Chemotherapy· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous mastocytosis: A dermatological perspective.
Cosimo Di Raimondo, Ester Del Duca, Dionisio Silvaggio, Monia Di Prete, Paolo Lombardo, Giulia Spallone

Australas J Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab.
Giulia Spallone, Alessandra Ventura, Mauro Mazzeo, Cosimo DI Raimondo, Paolo Lombardo

Ital J Dermatol Venerol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving.
Cosimo Di Raimondo, Mauro Mazzeo, Monia Di Prete, Paolo Lombardo, Dionisio Silvaggio, Giulia Spallone

Dermatol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
Maria Cristina Rapanotti, Elena Campione, Tara Mayte Suarez Viguria, Giulia Spallone, Gaetana Costanza

Front Mol Biosci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapy.
Giulia Spallone, Virginia Garofalo, Eliseo Picchi, Rossella Pitocco, Federico Bianchi

G Ital Dermatol Venereol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities.
Giulia Spallone, Pietro Sollena, Alessandra Ventura, Maria C Fargnoli, Carlota Gutierrez

Dermatol Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.
Maria Cristina Rapanotti, Elena Campione, Giulia Spallone, Augusto Orlandi, Sergio Bernardini

Cell Death Discov· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed cell death in the skin.
Antonio Costanzo, Francesca Fausti, Giulia Spallone, Francesca Moretti, Alessandra Narcisi

Int J Dev Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations.
Barbara Marinari, Elisabetta Botti, Mauro Bavetta, Giulia Spallone, Arianna Zangrilli

Drug Dev Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target.
Elisabetta Botti, Giulia Spallone, Roberta Caruso, Giovanni Monteleone, Sergio Chimenti

Curr Pharm Biotechnol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions.
Katrin Kerl, Werner Kempf, Jivko Kamarashev, Giulia Spallone, Ralph Braun

Arch Dermatol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM8 and p53: making the right decision.
Elisabetta Botti, Giulia Spallone, Antonio Costanzo

Cell Cycle· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.
Elisabetta Botti, Giulia Spallone, Francesca Moretti, Barbara Marinari, Valentina Pinetti

Proc Natl Acad Sci U S A· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy in nonmelanoma skin cancers.
Giulia Spallone, Elisabetta Botti, Antonio Costanzo

Cancers (Basel)· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efalizumab.
Marina Talamonti, Giulia Spallone, Alessandro Di Stefani, Antonio Costanzo, Sergio Chimenti

Expert Opin Drug Saf· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias.
Francesca Moretti, Barbara Marinari, Nadia Lo Iacono, Elisabetta Botti, Alessandro Giunta, Giulia Spallone

J Clin Invest· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy.
Antonio Costanzo, Marina Talamonti, Giulia Spallone, Elisabetta Botti, Maria Sole Chimenti

Dermatology· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis